Jump Financial, LLC Precigen, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.91 - $3.98 $79,052 - $164,728	-41,389 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$3.53 - $5.5 $146,103 - $227,639	41,389 New	41,389 $154,000
Q2 2021 Aug 13, 2021	SELL	$6.24 - $8.22 $64,527 - $85,003	-10,341 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $69,698 - $113,233	10,341 New	10,341 $71,000
Q4 2020 Feb 12, 2021	SELL	$3.75 - $10.56 $159,588 - $449,401	-42,557 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.5 - $6.2 $148,949 - $263,853	42,557 New	42,557 $149,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $187M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.